Loading...
The impact of the COVID-19 pandemic upon pancreatic cancer treatment (CONTACT Study): a UK national observational cohort study
Hall, L. A. ; McKay, S. C. ; Halle-Smith, J. ; Soane, J. ; Osei-Bordom, D. C. ; Goodburn, L. ; Magill, L. ; Pinkney, T. ; Radhakrishna, G. ; ... show 2 more
Hall, L. A.
McKay, S. C.
Halle-Smith, J.
Soane, J.
Osei-Bordom, D. C.
Goodburn, L.
Magill, L.
Pinkney, T.
Radhakrishna, G.
Citations
Altmetric:
Abstract
Introduction: CONTACT is a national multidisciplinary study assessing the impact of the COVID-19 pandemic upon diagnostic and treatment pathways among patients with pancreatic ductal adenocarcinoma (PDAC).
Methods: The treatment of consecutive patients with newly diagnosed PDAC from a pre-COVID-19 pandemic cohort (07/01/2019-03/03/2019) were compared to a cohort diagnosed during the first wave of the UK pandemic ('COVID' cohort, 16/03/2020-10/05/2020), with 12-month follow-up.
Results: Among 984 patients (pre-COVID: n = 483, COVID: n = 501), the COVID cohort was less likely to receive staging investigations other than CT scanning (29.5% vs. 37.2%, p = 0.010). Among patients treated with curative intent, there was a reduction in the proportion of patients recommended surgery (54.5% vs. 76.6%, p = 0.001) and increase in the proportion recommended upfront chemotherapy (45.5% vs. 23.4%, p = 0.002). Among patients on a non-curative pathway, fewer patients were recommended (47.4% vs. 57.3%, p = 0.004) or received palliative anti-cancer therapy (20.5% vs. 26.5%, p = 0.045). Ultimately, fewer patients in the COVID cohort underwent surgical resection (6.4% vs. 9.3%, p = 0.036), whilst more patients received no anti-cancer treatment (69.3% vs. 59.2% p = 0.009). Despite these differences, there was no difference in median overall survival between the COVID and pre-COVID cohorts, (3.5 (IQR 2.8-4.1) vs. 4.4 (IQR 3.6-5.2) months, p = 0.093).
Conclusion: Pathways for patients with PDAC were significantly disrupted during the first wave of the COVID-19 pandemic, with fewer patients receiving standard treatments. However, no significant impact on survival was discerned.
Description
Date
2023
Publisher
Collections
Files
Keywords
Type
Article
Citation
Hall LA, McKay SC, Halle-Smith J, Soane J, Osei-Bordom DC, Goodburn L, et al. The impact of the COVID-19 pandemic upon pancreatic cancer treatment (CONTACT Study): a UK national observational cohort study. British journal of cancer. 2023 Mar 23:1-11. PubMed PMID: 36959376. Pubmed Central PMCID: PMC10035482. Epub 2023/03/25. eng.